Fipexide
From Wikipedia, the free encyclopedia
ATC code | N06BX05 (WHO) |
---|---|
Identifiers | |
Systematic (IUPAC) name: 1-[4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl]-
2-(4-chlorophenoxy)ethanone |
|
CAS Number | 34161-24-5 |
PubChem (CID) | 3351 |
ChemSpider | 3234 |
UNII | TG44VME01D |
KEGG | D07345 |
ChEMBL | CHEMBL254857 |
Chemical and physical data | |
Formula | C20H21ClN2O4 |
Molar mass | 388.845 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(verify) |
Fipexide (Attentil, Vigilor) is a psychoactive drug of the piperazine chemical class which was developed in Italy in 1983.[1] It was used as a nootropic drug in Italy and France, mainly for the treatment of senile dementia,[2] but is no longer in common use due to the occurrence of rare adverse drug reactions including fever[3] and hepatitis. Fipexide is similar in action to other nootropic drugs such as piracetam and is structurally similar to another more well-known nootropic, centrophenoxine. Chemically, it is an amide union of parachlorophenoxyacetate and methylenedioxybenzylpiperazine (MDBZP), and has been shown to metabolize to the latter, which plays a significant role in its effects.
See also[edit]
References[edit]
- ^ Missale C, Pasinetti G, Govoni S, Spano PF, Trabucchi M. Fipexide: a new drug for the regulation of dopaminergic system at the macromolecular level. Bollettino Chimico Farmaceutico. 1983 Feb;122(2):79-85.
- ^ Bompani R, Scali G. Fipexide, an effective cognition activator in the elderly: a placebo-controlled, double-blind clinical trial. Current Medical Research and Opinion. 1986;10(2):99-106.
- ^ Guy C, Blay N, Rousset H, Fardeau V, Ollagnier M. Fever caused by fipexide. Evaluation of the national pharmacovigilance survey. Therapie. 1990 Sep-Oct;45(5):429-31.
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |